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Introduction: We report the case of a patient who was diagnosed as having pneumatosis cystoides intestinalis while
being treated with prednisolone for bronchial asthma. Even before we had experienced a case of this, the relationship
between pneumatosis cystoides intestinalis and prednisolone was unclear. In this case, pneumatosis cystoides
intestinalis was improved with the reduction of prednisolone, and therefore we thought a direct relationship between
pneumatosis cystoides intestinalis and prednisolone might become clear, such as whether it is dose dependent.
Case presentation: A 62-year-old Japanese woman had been treated for bronchial asthma for approximately 40 years.
She presented with abdominal distension, and a radiographic examination showed intraperitoneal free gas and
intramural gas, suggestive of pneumatosis cystoides intestinalis. However, when her prednisolone dose was decreased
from 30mg to 0mg for approximately a year because of improvement in her asthma symptoms, her abdominal
symptom resolved, and the frequency of her bowel movements returned to normal.
Conclusion: Amelioration of pneumatosis cystoides intestinalis was observed with tapering of the prednisolone,
suggesting that prednisolone may have been involved in the pathogenesis of pneumatosis cystoides intestinalis
in this patient.
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Pneumatosis cystoides intestinalis (PCI) is a rare condition
in which multiple pneumatocysts develop in the submucosa
or subserosa of the colon. PCI was first reported in
anatomic dissection by DuVernoi in 1730, and Meyer was
the first to use the term in 1925 [1,2]. PCI is characterized
by multiple gas-filled cysts in the wall of the large intestine
[1], and is an unexpected radiologic finding in many cases
[1]. Abdominal pain is the most frequent complaint. We
encountered a case of PCI apparently induced by a steroid
used for asthma treatment, which resolved with tapering of
the steroid.
Case presentation
A 62-year-old Japanese woman was observed for ap-
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reproduction in any medium, provided the orhowever, an upper gastrointestinal endoscopy, fluoroscopic
examination and abdominal computed tomography (CT)
revealed no abnormal findings. Thereafter, the patient’s
symptom settled. Four years later, she visited our hospital
because of a feeling of fullness in the abdomen and increase
in the frequency of bowel movements. An abdominal CT
revealed extensive appearance of intramural gas in the
colon (Figure 1), particularly in the ascending portion. No
abnormality was noted on the surface of the intestinal wall
by colonoscopy, except for soft polypoid lesions (Figures 2
and 3). The soft polypoid lesions were 6mm in diameter, on
average, with a maximum diameter of 33mm. Pathological
examination revealed a cluster of pneumatic cysts in the
submucosa and subserosa of the colon, based on which
the diagnosis of PCI was made (Figure 4). There was no
evidence of inflammation, despite her abdominal symp-
toms and laboratory findings, including elevated serum
C-reactive protein levels and leukocytosis. She has had
hypertension, hyperlipidemia, and asthma for decades.
She was taking the following routine daily medications:td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Abdominal computed tomography scan examination
showing extensive appearance of intramural gas in the colon.
Figure 3 Lower gastrointestinal tract contrast study showing
air accumulation in the ascending colon.
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and butropium bromide. These medications were contin-
ued during the treatment period for bronchial asthma.
Prednisolone (PSL) was started at a dose of 30mg/day. Dur-
ing the observation period, the severity of the bronchial
asthma symptoms fluctuated. The PSL dose was gradually
tapered as the asthma symptoms improved; PSL 30mg was
administered each time the asthmatic symptoms increased
in severity during the observation period. PSL was the only
drug whose dose was modified during the same period.
Discussion
PCI is characterized by the development of multiple sub-
mucosal or subserosal pneumatocysts in the submucosa or
subserosa of the colon [3-5]. An abdominal X-ray and CTFigure 2 Colonoscopy showing soft polypoid lesions in the
digestive tract.
Figure 4 Pathological findings showed pneumatic cysts in the
submucosa and subserosa (×50).
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mulation in the intestinal wall, particularly in the colon,
leading to the diagnosis of PCI [6]. The etiological mecha-
nisms of PCI are unclear, although PCI has been reported
to develop in association with raised intra-abdominal
pressure due to ileus surgery, colonoscopy, pulmonary
diseases such as chronic bronchitis and emphysema,
trichloroethylene exposure, connective tissue disorders,
and use of immune-suppressants and alpha-glucosidase
inhibitors [3,4]. PSL reduces the number of lymphocytes
in the gastrointestinal wall, particularly in the Peyer’s
patches, impairing the bowel defense barrier system [7],
and causes fragility of the intestinal wall, decreased bowel
movements, and excessive intraluminal air production [6].
Both bronchial asthma and PSL can cause PCI. Therefore,
we could not exclude either as the cause of the PCI in this
patient. However, the patient had received PSL for a
prolonged period of time, and the possibility of her devel-
oping diabetes was high; however, there were no abnor-
malities in the blood glucose concentration or serum
HbA1c, therefore, she did not receive any antidiabetic
drug, particularly voglibose. The suspected etiopathogenic
mechanism is alveolar air leakage secondary to high
airway pressures [8]. Although the very high intrathoracic
pressure observed in our patient may have been responsible
for such air leakage and contributed to the development of
the PCI, gas collections in most cases of PCI associated
with pulmonary obstructive diseases occur in the large
bowel. It is a secondary finding associated with a wide var-
iety of underlying gastrointestinal or extragastrointestinal
diseases, such as autoimmune disease (scleroderma, derm-
atomyositis), inflammatory disease (inflammatory bowel
disease), and infectious diseases (Clostridium difficile,
human immunodeficiency virus), pulmonary disease
(chronic obstructive pulmonary disease, bronchial asthma),
drugs (corticosteroids, immunosuppressive therapy), and
trauma (blunt abdominal trauma, endoscopy) [1]. In
addition, there are also reports on the relationship of
pneumomediastinum with PCI. Both pneumomediastinum
and PCI can arise as a result of mesenteric ischemia, and
therefore occur in patients with ischemic diseases such as
acute mesenteric ischemia [9-12].
Conclusions
This patient was diagnosed as having asthma when she
was 25-years old, and had been under treatment with
PSL for 13 years. She suffered from abdominal pain two
or three times per month after having been initiated on
treatment with PSL 30mg, however, the abdominal symp-
tom resolved after tapering of PSL. Therefore, develop-
ment of PCI in the present patient was probably related to
the use of PSL 30mg. High-dose PSL and the long-term
use of the drug have been reported as risk factors for the
development of PCI. She showed dramatic improvementfollowing tapering of the steroid, and is asymptomatic at
the present time. At first, we considered whether the onset
of PCI depended on the amount of PSL, but the relation-
ship remains unclear. However, because the PCI had im-
proved in parallel with the reduction of the steroid dose,
we suggest that the gradual decrease of the steroid dose
may have contributed significantly to the improvement of
the PCI in our patient. It is noted that PSL is one of the
drugs most commonly associated with the development of
PCI [1,6]. If a patient being treated with PSL complains of
abdominal pain, testing for suspected PCI is needed [1].Consent
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